Franklin Covey (FC) has just posted its Q3 2026 numbers, with revenue of $67.8 million and basic EPS of $0.27, setting the tone for how investors assess its recent profitability. The company has seen revenue move from $67.1 million in Q3 2025 to $67.8 million in Q3 2026, while basic EPS shifted from a loss of $0.11 to a profit of $0.27 over the same period. This frames a clear earnings swing alongside a relatively stable top line. For investors, the latest quarter highlights how margins are currently doing more of the work in the story than headline revenue.

See our full analysis for Franklin Covey.

With the quarterly picture in place, the next step is to set these results against the prevailing market and community narratives to see which views about Franklin Covey hold up and which ones the numbers start to challenge.

Margin Swing Shows Up in Net Income

• Net income moved from a loss of US$1.4 million in Q3 2025 to a profit of US$3.1 million in Q3 2026, while total revenue over the same quarters stayed in a tight range around US$67 million.
• Bears highlight that over the last 12 months Franklin Covey’s net profit margin was 0.8% compared with 3.8% a year earlier, and that reported earnings have declined about 19.2% per year over five years, which sits uncomfortably alongside this single quarter’s improvement in profit.

High P/E and DCF Gap Create Tension

• The stock trades on a trailing P/E of 112.6x versus about 19.7x for the US Professional Services industry and 25.1x for peers, while a DCF fair value of US$80.04 compares with a current share price of US$21.78.
• Consensus narrative notes a price target of US$31.00, which sits well below the DCF fair value but above today’s share price, creating a middle ground between models that see the shares trading roughly 72.8% below DCF fair value and critics who point to the high P/E:
  • The trailing 12 month net income of US$2.2 million against roughly US$262.7 million of revenue helps explain why the trailing P/E is so elevated.
  • At the same time, the gap between the US$21.78 share price and the US$31.00 target reflects that some analysts still see room for upside even after factoring in weaker recent margins.

Analysts who want to see how these valuation signals tie back to the story around Franklin Covey can check the wider market narrative in more detail with the See what the community is saying about Franklin Covey

Earnings Forecasts Lean on Margin Recovery

• Forecasts in the dataset point to very large forecast earnings growth of 121% per year over the next three years, compared with forecast revenue growth of 4.6% per year and a recent one off loss of US$6.4 million included in the trailing 12 month figures.
• What stands out in the bullish narrative is how much of the thesis depends on margins rebuilding from weak recent levels, including expectations that profit margins rise from a recent figure around 3.8% to 5.2% over a few years, even though the latest trailing 12 month margin is 0.8% and includes that US$6.4 million one off loss:
  • This focus on margin improvement lines up with the shift from losses in Q1 and Q2 2026 to a profit of US$3.1 million in Q3 2026, but the low trailing margin shows the recovery is still early in the longer term data.
  • The modest forecast revenue growth of 4.6% per year means a large part of the 121% expected earnings growth would need to come from better profitability rather than a big step up in the top line.

For readers who want to see how strongly supporters think this margin story can play out over time, the full bull case around Franklin Covey is laid out in 🐂 Franklin Covey Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Franklin Covey on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If this mix of risks and rewards around Franklin Covey feels finely balanced, do not wait on others to make the call for you. Instead, check the 2 key rewards and 2 important warning signs.

See What Else Is Out There Beyond Franklin Covey

Franklin Covey’s weak trailing margins, high P/E of 112.6x, and modest forecast revenue growth put a lot of pressure on future profitability to justify the current valuation.

If that dependency on margin recovery feels uncomfortable, it makes sense to compare Franklin Covey with companies that already combine quality with more appealing pricing by checking the 42 high quality undervalued stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.